Twinbeech Capital LP Makes New Investment in Encompass Health Co. (NYSE:EHC)

Twinbeech Capital LP bought a new stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 42,154 shares of the company's stock, valued at approximately $3,893,000.

A number of other institutional investors have also recently made changes to their positions in the company. Park Avenue Securities LLC increased its holdings in shares of Encompass Health by 44.7% in the 4th quarter. Park Avenue Securities LLC now owns 6,737 shares of the company's stock worth $622,000 after purchasing an additional 2,082 shares in the last quarter. Merit Financial Group LLC bought a new stake in shares of Encompass Health in the 4th quarter worth $374,000. Ameritas Advisory Services LLC bought a new stake in shares of Encompass Health in the 4th quarter worth $380,000. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Encompass Health by 0.3% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 302,272 shares of the company's stock worth $27,915,000 after purchasing an additional 830 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Activity

In other news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the sale, the executive vice president now directly owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer now directly owns 527,070 shares in the company, valued at $64,054,817.10. This trade represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock worth $16,034,082 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Encompass Health Stock Performance

NYSE EHC traded up $0.13 on Friday, hitting $118.74. 388,011 shares of the company traded hands, compared to its average volume of 698,046. The company has a market capitalization of $11.97 billion, a price-to-earnings ratio of 26.62, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The business's 50 day moving average price is $107.85 and its 200-day moving average price is $101.42. Encompass Health Co. has a 52-week low of $82.74 and a 52-week high of $121.96.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.12 earnings per share. Equities analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Analyst Ratings Changes

EHC has been the subject of a number of research analyst reports. KeyCorp lifted their target price on Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Barclays lifted their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Royal Bank of Canada lifted their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Finally, UBS Group lifted their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.